Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Liver transplant from an ABO-incompatible and hepatitis C antibody-positive but an HCV-RNA negative living donor in a familial amyloid polyneuropathy patient.

Takeichi T, Asonuma K, Yamamoto H, Ohya Y, Okumura K, Lee KJ, Inomata Y.

Exp Clin Transplant. 2013 Apr;11(2):182-5. doi: 10.6002/ect.2012.0158.

2.

Case Report of an ABO-Incompatible Living-Donor Liver Transplant for a Familial Amyloid Polyneuropathy Patient.

Nakanuma S, Takamura H, Shoji M, Hayashi H, Tajima H, Nakagawara H, Miyashita T, Kitagawa H, Tani T, Ohta T.

Exp Clin Transplant. 2015 Oct;13(5):479-81. doi: 10.6002/ect.2014.0076.

3.

ABO-incompatible auxiliary partial orthotopic liver transplant for late-onset familial amyloid polyneuropathy.

Watanabe H, Misu K, Kobayashi T, Hattori N, Doyu M, Yokoyama I, Ando Y, Nakao A, Sobue G.

J Neurol Sci. 2002 Mar 15;195(1):63-6.

PMID:
11867075
4.
5.

Liver transplantation from anti-hepatitis C virus-positive donors: our experience.

Álvaro E, Abradelo M, Fuertes A, Manrique A, Colina F, Alegre C, Calvo J, García M, García-Sesma A, Cambra F, Sanabria R, Moreno E, Jimenez C.

Transplant Proc. 2012 Jul-Aug;44(6):1475-8. doi: 10.1016/j.transproceed.2012.05.012.

PMID:
22841188
6.

Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.

Yosry A, Abdel-Rahman M, Esmat G, El-Serafy M, Omar A, Doss W, Zayed N, Said M, Ismail T, Hosny A, Marawan E, El-Malt O, Kamel RR, Hatata Y, El-Taweel A, Ghali A, Sabri H, Kamel S, El-Gabaly H.

Exp Clin Transplant. 2009 Sep;7(3):157-63.

7.

Usefulness of liver biopsy in anti-hepatitis C virus antibody-positive and hepatitis C virus RNA-negative kidney transplant recipients.

Kim SM, Kim HW, Lee EK, Park SK, Han DJ, Kim SB.

Transplantation. 2013 Jul 15;96(1):85-90. doi: 10.1097/TP.0b013e318294cad1.

PMID:
23632392
8.

[ABO incompatible living donor kidney transplantation: a dream come true. Experience of Hospital Clínic of Barcelona].

Oppenheimer F, Revuelta I, Serra N, Lozano M, Gutiérrez-Dalmau A, Esforzado N, Cofán F, Ricart MJ, Torregrosa JV, Crespo M, Paredes D, Martorell J, Alcáraz A, Campistol JM.

Nefrologia. 2010;30(1):54-63. doi: 10.3265/Nefrologia.pre2009.Dic.5695. Spanish.

9.

Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.

Ishikawa N, Yagisawa T, Sakuma Y, Fujiwara T, Nukui A, Yashi M, Miyamoto N.

Transplant Proc. 2008 Sep;40(7):2292-3. doi: 10.1016/j.transproceed.2008.06.024.

PMID:
18790215
10.

Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation.

Egawa H, Oike F, Buhler L, Shapiro AM, Minamiguchi S, Haga H, Uryuhara K, Kiuchi T, Kaihara S, Tanaka K.

Transplantation. 2004 Feb 15;77(3):403-11.

PMID:
14966415
11.

Helicobacter cinaedi bacteremia with cellulitis after ABO-incompatible living-donor liver transplantation: Case report.

Mishima K, Obara H, Sugita K, Shinoda M, Kitago M, Abe Y, Hibi T, Yagi H, Matsubara K, Mori T, Takano Y, Fujiwara H, Itano O, Hasegawa N, Iwata S, Kitagawa Y.

World J Gastroenterol. 2015 Jul 7;21(25):7911-5. doi: 10.3748/wjg.v21.i25.7911.

12.

Kinetics of anti-blood type isoagglutinin titers and B lymphocytes in ABO-incompatible living donor liver transplantation with rituximab and plasma exchange.

Uchiyama H, Mano Y, Taketomi A, Soejima Y, Yoshizumi T, Ikegami T, Shirabe K, Maehara Y.

Transplantation. 2011 Nov 27;92(10):1134-9. doi: 10.1097/TP.0b013e318231e9f8.

PMID:
21946174
13.

Hepatitis C transmission and infection by orthotopic heart transplantation.

Pfau PR, Rho R, DeNofrio D, Loh E, Blumberg EA, Acker MA, Lucey MR.

J Heart Lung Transplant. 2000 Apr;19(4):350-4.

PMID:
10775815
14.

The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.

Ashizawa T, Matsuno N, Yokoyama T, Kihara Y, Kuzuoka K, Taira S, Konno O, Jyojima Y, Akashi I, Nakamura Y, Hama K, Iwamoto H, Iwahori T, Nagao T, Kasahara M, Tanaka K.

Transplant Proc. 2006 Dec;38(10):3629-32.

PMID:
17175351
15.

Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier.

Song GW, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, Kwon SW, Ko GY, Kim KW.

Liver Transpl. 2010 Apr;16(4):491-8. doi: 10.1002/lt.22016.

16.

Temporary auxiliary liver transplantation from a living donor to an adult recipient with familial amyloid polyneuropathy.

Ikegami T, Kawasaki S, Ohno Y, Chisuwa H, Urata K, Nakazawa Y, Hashikura Y, Terada M, Miyagawa S, Takei Yi Y, Tokuda T, Ikeda Si S.

Transplantation. 2002 Feb 27;73(4):628-30.

PMID:
11889444
17.

Kidney transplantation from a donor who is HCV antibody positive and HCV-RNA negative.

Tokumoto T, Tanabe K, Simizu T, Shimmura H, Iizuka J, Ishikawa N, Oshima T, Yagisawa T, Goya N, Nakazawa H, Toma H.

Transplant Proc. 2000 Nov;32(7):1597-9. No abstract available.

PMID:
11119853
18.

Peritransplant gastrointestinal symptoms in familial amyloidotic polyneuropathy.

Ohya Y, Isono K, Obayashi K, Hayashida S, Lee KJ, Yamamoto H, Takeichi T, Asonuma K, Ando Y, Inomata Y.

Exp Clin Transplant. 2013 Aug;11(4):327-31. doi: 10.6002/ect.2012.0257.

19.

ABO-Incompatible Living Donor Liver Transplantation from Hepatitis B Core Antibody Positive Donor to Hepatitis C Liver Cirrhosis Recipient: A Case Report.

Umemura A, Nitta H, Sasaki A, Takahara T, Hasegawa Y, Wakabayashi G.

Case Rep Transplant. 2014;2014:507621. doi: 10.1155/2014/507621.

20.

Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: prospective study.

Gutiérrez-Moreno M, Bernal-Bellido C, Suárez-Artacho G, Alamo-Martínez JM, Marín-Gómez LM, Serrano-Díaz-Canedo J, Padillo-Ruiz FJ, Gómez-Bravo MA.

Transplant Proc. 2012 Sep;44(7):2100-2. doi: 10.1016/j.transproceed.2012.07.074.

PMID:
22974923
Items per page

Supplemental Content

Support Center